Filing Details
- Accession Number:
- 0000929638-21-000726
- Form Type:
- 13G Filing
- Publication Date:
- 2021-05-18 20:00:00
- Filed By:
- Cormorant Asset Management
- Company:
- Revolution Medicines Inc. (NASDAQ:RVMD)
- Filing Date:
- 2021-05-19
- SEC Url:
- 13G Filing
Ownership Summary
Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.
| Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
|---|---|---|---|---|---|---|
| Cormorant Global Healthcare Master Fund | 0 | 2,047,079 | 0 | 2,047,079 | 2,047,079 | 2.8% |
| Cormorant Global Healthcare GP | 0 | 2,047,079 | 0 | 2,047,079 | 2,047,079 | 2.8% |
| Cormorant Private Healthcare Fund II | 0 | 1,545,066 | 0 | 1,545,066 | 1,545,066 | 2.1% |
| Cormorant Private Healthcare GP II | 0 | 1,545,066 | 0 | 1,545,066 | 1,545,066 | 2.1% |
| Cormorant Asset Management | 0 | 3,675,000 | 0 | 3,675,000 | 3,675,000 | 5.0% |
| Bihua Chen | 0 | 3,675,000 | 0 | 3,675,000 | 3,675,000 | 5.0% |
Filing
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 |
| SCHEDULE 13G | ||
| Under the Securities Exchange Act of 1934 | ||
| (Amendment No. )* |
| Revolution Medicines, Inc. | ||
| (Name of Issuer) |
| Common Stock | ||
| (Title of Class of Securities) |
| 76155X100 | ||
| (CUSIP Number) |
| May 18, 2021 | ||
| (Date of Event which Requires Filing of this Statement) |
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
[ ] Rule
13d-1(b)
[x] Rule
13d-1(c)
[ ] Rule
13d-1(d)
___________________________________
* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for
any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934
(“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
| 1 | Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only) Cormorant Global Healthcare Master Fund, LP |
| 2 | Check the Appropriate Box if a Member of a Group (See Instructions) |
| (a) [ ] | |
| (b) [x] | |
| 3 | SEC Use Only |
| 4 | Citizenship or Place of Organization. Cayman Islands |
| Number of Shares Beneficially Owned by Each Reporting Person With | 5 Sole Voting Power 0 shares |
| 6 Shared Voting Power 2,047,079 shares Refer to Item 4 below. | |
| 7 Sole Dispositive Power 0 shares | |
| 8 Shared Dispositive Power 2,047,079 shares Refer to Item 4 below. |
| 9 | Aggregate Amount Beneficially Owned by Each Reporting Person 2,047,079 shares Refer to Item 4 below. | |
| 10 | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] N/A | |
| 11 | Percent of Class Represented by Amount in Row (9)* 2.8% Refer to Item 4 below. | |
| 12 | Type of Reporting Person (See Instructions) PN (Partnership) |
| 1 | Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only) Cormorant Global Healthcare GP, LLC |
| 2 | Check the Appropriate Box if a Member of a Group (See Instructions) |
| (a) [ ] | |
| (b) [x] | |
| 3 | SEC Use Only |
| 4 | Citizenship or Place of Organization. Delaware |
| Number of Shares Beneficially Owned by Each Reporting Person With | 5 Sole Voting Power 0 shares |
| 6 Shared Voting Power 2,047,079 shares Refer to Item 4 below. | |
| 7 Sole Dispositive Power 0 shares | |
| 8 Shared Dispositive Power 2,047,079 shares Refer to Item 4 below. |
| 9 | Aggregate Amount Beneficially Owned by Each Reporting Person 2,047,079 shares Refer to Item 4 below. | |
| 10 | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] N/A | |
| 11 | Percent of Class Represented by Amount in Row (9)* 2.8% Refer to Item 4 below. | |
| 12 | Type of Reporting Person (See Instructions) OO (Limited Liability Company) |
| 1 | Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only) Cormorant Private Healthcare Fund II, LP |
| 2 | Check the Appropriate Box if a Member of a Group (See Instructions) |
| (a) [ ] | |
| (b) [x] | |
| 3 | SEC Use Only |
| 4 | Citizenship or Place of Organization. Delaware |
| Number of Shares Beneficially Owned by Each Reporting Person With | 5 Sole Voting Power 0 shares |
| 6 Shared Voting Power 1,545,066 shares Refer to Item 4 below. | |
| 7 Sole Dispositive Power 0 shares | |
| 8 Shared Dispositive Power 1,545,066 shares Refer to Item 4 below. |
| 9 | Aggregate Amount Beneficially Owned by Each Reporting Person 1,545,066 shares Refer to Item 4 below. | |
| 10 | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] N/A | |
| 11 | Percent of Class Represented by Amount in Row (9)* 2.1% Refer to Item 4 below. | |
| 12 | Type of Reporting Person (See Instructions) PN (Partnership) |
| 1 | Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only) Cormorant Private Healthcare GP II, LLC |
| 2 | Check the Appropriate Box if a Member of a Group (See Instructions) |
| (a) [ ] | |
| (b) [x] | |
| 3 | SEC Use Only |
| 4 | Citizenship or Place of Organization. Delaware |
| Number of Shares Beneficially Owned by Each Reporting Person With | 5 Sole Voting Power 0 shares |
| 6 Shared Voting Power 1,545,066 shares Refer to Item 4 below. | |
| 7 Sole Dispositive Power 0 shares | |
| 8 Shared Dispositive Power 1,545,066 shares Refer to Item 4 below. |
| 9 | Aggregate Amount Beneficially Owned by Each Reporting Person 1,545,066 shares Refer to Item 4 below. | |
| 10 | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] N/A | |
| 11 | Percent of Class Represented by Amount in Row (9)* 2.1% Refer to Item 4 below. | |
| 12 | Type of Reporting Person (See Instructions) OO (Limited Liability Company) |
| 1 | Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only) Cormorant Asset Management, LP |
| 2 | Check the Appropriate Box if a Member of a Group (See Instructions) |
| (a) [ ] | |
| (b) [x] | |
| 3 | SEC Use Only |
| 4 | Citizenship or Place of Organization. Delaware |
| Number of Shares Beneficially Owned by Each Reporting Person With | 5 Sole Voting Power 0 shares |
| 6 Shared Voting Power 3,675,000 shares Refer to Item 4 below. | |
| 7 Sole Dispositive Power 0 shares | |
| 8 Shared Dispositive Power 3,675,000 shares Refer to Item 4 below. |
| 9 | Aggregate Amount Beneficially Owned by Each Reporting Person 3,675,000 shares Refer to Item 4 below. | |
| 10 | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] N/A | |
| 11 | Percent of Class Represented by Amount in Row (9)* 5.0% Refer to Item 4 below. | |
| 12 | Type of Reporting Person (See Instructions) PN (Partnership) |
| 1 | Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only) Bihua Chen |
| 2 | Check the Appropriate Box if a Member of a Group (See Instructions) |
| (a) [ ] | |
| (b) [x] | |
| 3 | SEC Use Only |
| 4 | Citizenship or Place of Organization. United States |
| Number of Shares Beneficially Owned by Each Reporting Person With | 5 Sole Voting Power 0 shares |
| 6 Shared Voting Power 3,675,000 shares Refer to Item 4 below. | |
| 7 Sole Dispositive Power 0 shares | |
| 8 Shared Dispositive Power 3,675,000 shares Refer to Item 4 below. |
| 9 | Aggregate Amount Beneficially Owned by Each Reporting Person 3,675,000 shares Refer to Item 4 below. | |
| 10 | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] N/A | |
| 11 | Percent of Class Represented by Amount in Row (9)* 5.0% Refer to Item 4 below. | |
| 12 | Type of Reporting Person (See Instructions) IN (Individual) |
Item 1.
| (a) | Name of Issuer |
| Revolution Medicines, Inc. | |
| (b) | Address of Issuer’s Principal Executive Offices |
| 700 Saginaw Drive, Redwood City, California 94063 |
Item 2.
| (a) | Name of Person Filing |
| Cormorant Global Healthcare Master Fund, LP Cormorant Global Healthcare GP, LLC Cormorant Private Healthcare Fund II, LP Cormorant Private Healthcare GP II, LLC Cormorant Asset Management, LP Bihua Chen | |
| (b) | Address of Principal Business Office or, if none, Residence |
| 200 Clarendon Street, 52nd Floor Boston, MA 02116 | |
| (c) | Citizenship |
| Cormorant Global Healthcare Master Fund, LP - Cayman Islands Cormorant Global Healthcare GP, LLC - Delaware Cormorant Private Healthcare Fund II, LP - Delaware Cormorant Private Healthcare GP II, LLC - Delaware Cormorant Asset Management, LP - Delaware Bihua Chen - United States | |
| (d) | Title of Class of Securities |
| Common Stock | |
| (e) | CUSIP Number |
| 76155X100 |
| Item 3. | If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: |
| (a) | [ ] | Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o). |
| (b) | [ ] | Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). |
| (c) | [ ] | Insurance Company as defined in Section 3(a)(19) of the Act |
| (d) | [ ] | Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). |
| (e) | [ ] | An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E); |
| (f) | [ ] | An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F); |
| (g) | [ ] | A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G); |
| (h) | [ ] | A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); |
| (i) | [ ] | A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); |
| (j) | [ ] | A non-U.S. institution in accordance with §240.13d–1(b)(1)(ii)(J); |
| (k) | [ ] | Group, in accordance with §240.13d-1(b)(1)(ii)(K). |
| Item 4. | Ownership*** |
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
| (a) | Amount Beneficially Owned*** |
| Cormorant Global Healthcare Master Fund, LP – 2,047,079 shares Cormorant Global Healthcare GP, LLC – 2,047,079 shares Cormorant Private Healthcare Fund II, LP – 1,545,066 shares Cormorant Private Healthcare GP II, LLC – 1,545,066 shares Cormorant Asset Management, LP – 3,675,000 shares Bihua Chen – 3,675,000 shares | |
| (b) | Percent of Class |
| Cormorant Global Healthcare Master Fund, LP – 2.8% Cormorant Global Healthcare GP, LLC – 2.8% Cormorant Private Healthcare Fund II, LP – 2.1% Cormorant Private Healthcare GP II, LLC – 2.1% Cormorant Asset Management, LP – 5.0% Bihua Chen – 5.0% |
| (c) | Number of shares as to which such person has: | |
| (i) | sole power to vote or to direct the vote | |
| Cormorant Global Healthcare Master Fund, LP - 0 shares Cormorant Global Healthcare GP, LLC - 0 shares Cormorant Private Healthcare Fund II, LP – 0 shares Cormorant Private Healthcare GP II, LLC – 0 shares Cormorant Asset Management, LP - 0 shares Bihua Chen - 0 shares | ||
| (ii) | shared power to vote or to direct the vote | |
| Cormorant Global Healthcare Master Fund, LP – 2,047,079 shares Cormorant Global Healthcare GP, LLC – 2,047,079 shares Cormorant Private Healthcare Fund II, LP – 1,545,066 shares Cormorant Private Healthcare GP II, LLC – 1,545,066 shares Cormorant Asset Management, LP – 3,675,000 shares Bihua Chen – 3,675,000 shares | ||
| (iii) | sole power to dispose or to direct the disposition of | |
| Cormorant Global Healthcare Master Fund, LP - 0 shares Cormorant Global Healthcare GP, LLC - 0 shares Cormorant Private Healthcare Fund II, LP – 0 shares Cormorant Private Healthcare GP II, LLC – 0 shares Cormorant Asset Management, LP - 0 shares Bihua Chen - 0 shares | ||
| (iv) | shared power to dispose or to direct the disposition of | |
| Cormorant Global Healthcare Master Fund, LP – 2,047,079 shares Cormorant Global Healthcare GP, LLC – 2,047,079 shares Cormorant Private Healthcare Fund II, LP – 1,545,066 shares Cormorant Private Healthcare GP II, LLC – 1,545,066 shares Cormorant Asset Management, LP – 3,675,000 shares Bihua Chen – 3,675,000 shares | ||
*** Shares reported herein for Cormorant Asset Management, LP represent shares which are beneficially by Cormorant Global
Healthcare Master Fund, LP (the “Master Fund”) and Cormorant Private Healthcare Fund II, LP (“Fund II”), as reported herein, and a managed account (the “Account”). Cormorant Global Healthcare GP, LLC and Cormorant Private Healthcare GP II, LLC serve
as the general partners of the Master Fund and Fund II, respectively. Cormorant Asset Management, LP serves as the investment manager to the Master Fund, Fund II and the Account. Bihua Chen serves as the managing member of Cormorant Global
Healthcare GP, LLC, Cormorant Private Healthcare GP II, LLC and the general partner of Cormorant Asset Management, LP. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or his
pecuniary interest therein.
The percentages reported herein with respect to the Reporting Persons' holdings are calculated based upon there being 73,442,594
shares of Common Stock outstanding as of May 5, 2021, as reported in the Issuer's Form 10-Q for the quarter ended March 31, 2021, as filed with the Securities and Exchange Commission on May 10, 2021.
Item 5. Ownership of Five Percent or Less of a
Class
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more
than five percent of the class of securities, check the following [ ].
Item 6. Ownership of More than Five Percent on
Behalf of Another Person
Not applicable.
Item 7. Identification and Classification of the
Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company
Not applicable.
| Item 8. | Identification and Classification of Members of the Group |
Not applicable.
| Item 9. | Notice of Dissolution of Group |
Not applicable.
| Item 10. | Certification |
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with
the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
Exhibits Exhibit
99.1 Joint Filing Agreement by and among the Reporting Persons, incorporated by reference to Exhibit 99.1 to Schedule 13G filed by the Reporting Persons with the Securities and Exchange Commission on February 24, 2020.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this Statement is true, complete
and correct.
May 19, 2021
CORMORANT GLOBAL HEALTHCARE MASTER FUND, LP
By: Cormorant Global Healthcare GP, LLC
its General Partner
By: /s/ Bihua Chen
Bihua Chen, Managing Member
CORMORANT GLOBAL HEALTHCARE GP, LLC
By: /s/ Bihua Chen
Bihua Chen, Managing Member
CORMORANT PRIVATE HEALTHCARE FUND II, LP
By: Cormorant Global Healthcare GP II, LLC
its General Partner
By: /s/ Bihua Chen
Bihua Chen, Managing Member
CORMORANT PRIVATE HEALTHCARE GP II, LLC
By: /s/ Bihua Chen
Bihua Chen, Managing Member
CORMORANT ASSET MANAGEMENT, LP
By: Cormorant Asset Management GP, LLC
its General Partner
By: /s/ Bihua Chen
Bihua Chen, Managing Member
/s/ Bihua Chen
Bihua Chen